Company
United StatesCell Therapies Manufacturing Facility Hackensack University Medical Center, Hackensack, NJ – FDA Inspections
Inspection records and compliance data for Cell Therapies Manufacturing Facility Hackensack University Medical Center in Hackensack, New Jersey. 1 FDA inspection on record, last inspected July 14, 2022.
Company Profile
This profile covers Cell Therapies Manufacturing Facility Hackensack University Medical Center based in Hackensack, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 14, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 14, 2022 | NAI | Biologics · Vaccines and Allergenic Products | 1175500 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Blood Center of New Jersey Muhlenberg Regional Medical Ctr.
Kourosh Asgarian, MD
RTI Biologics, Inc.
Xytex Cryo International
GXO Logistics Supply Chain Inc
Cooper Institute for Reproductive Hormonal Disorders, P.C.
New York Blood Center Inc
Holy Name Medical Center
Reproductive Medicine Associates of New Jersey LLC
Waintraub, Stanley E. MD
Company Information
Name
Cell Therapies Manufacturing Facility Hackensack University Medical Center
FEI Number
3014679694
Address
40 Prospect Ave, Hackensack, New Jersey 07601, United States
Country
United States
ID: d261378b-79d8-499b-9162-d2aba735ea9b